From Grants to Contracts: What Biotech Companies Need to Know About Federal Funding
Kate Green
By Dr. Melanie Doyle-Eisele, Senior Director of Life Sciences & Head of Federal Business Development Federal funding remains one of the most attractive opportunities for emerging and mid-sized life sciences companies. Grants and federal contracts offer the potential to accelerate research, validate innovation, and scale programs that might otherwise struggle to secure private investment. However, not all federal funding mechanisms operate ... Read More The post From Grants to Contracts: What Bio